Android Application Oncology Nursing Drug Handbook is available on GooglePlay Application Store ❤️. Oncology Nursing Drug Handbook app that has 1,000+ installed on smartphone in the world, with average rating 0.0 ★. To install Oncology Nursing Drug Handbook app version 2.0.1.98, you should have requirement minimum space and 5.0 and up Android Version. Oncology Nursing Drug Handbook App was created by AtmosphereApps. Mobile Developer in Medical Categories.

Content Rating of Oncology Nursing Drug Handbook App - Everyone, you should know that if Android Application is gonna be used by children. Warning, that software could have Ads and Paid Content, but we assure you that Oncology Nursing Drug Handbook com.atmoapps.onha.apk is Safe for 100% and AdFree. If You Want To Download Oncology Nursing Drug Handbook for your device Android system, you should do easy instruction. You need go to the Settings menu & allow the permission needed. After that, you could calmly download files, and confidently install it on your smartphone ❤️.

The description of Oncology Nursing Drug Handbook App

Written especially for nurses caring for patients with cancer, the Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. Updated annually, this essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration.

Completely revised and updated, the Oncology Nursing Drug Handbook includes separate chapters on molecular and immunologic/biologic targeted therapies. These chapters provide fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer. It also offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for recently FDA approved drugs.

New drugs include:

apalutamide (Erleada™)
calaspargase pegol-mknl (Asparlas™)
Daunorubicin and cytarabine liposome for injection (Vyxeos®)
glucarpidase (Voraxaze®)
alpelisib (Piqray®)
binimetinib (Mektovi®)
dacomitinib (Vizimpro®)
Duvelisib (Copiktra®)
encorafenib (Braftovi®)
erdafitinib (Balversa™)
lorlatinib (Lorbrena®)
anakinra (Kineret®)
baricitinib (Olumiant®)
sarilumab (Kevzara®)
aprepitant injectable emulsion (Cinvanti®)
granisetron hydrochloride extended-release injection (Sustol®)
letermovir (Prevymis™)
omadacycline (Nuzyra™)
meropenem/vaborbactam (Vabomere™)
Plazomicin (Zemdri™)
baloxavir marboxil (Xofluza™)
imipenem/cilastatin sodium/relebactam (Recarbrio™)
eravacycline (Xerava™)
delafloxacin (Baxdela™)